Israeli medical cannabis approved for export to Germany, France

Israel’s medical cannabis export industry is beginning to take shape. Leading Israeli medical cannabis company Panaxia received approvals to export their products to Germany and France earlier this week. On Wednesday, Panaxia, Israel’s largest manufacturer of medical cannabis products in Israel, announced that they had become the first company in ... Read More

Panaxia and Neuraxpharm Expand Strategic Collaboration to France with medical cannabis

TEL AVIV, Israel, Nov. 23, 2020 /PRNewswire/ — Panaxia Global, the controlling owner of Panaxia Labs Israel Ltd. (“Panaxia Israel”), (TASE: PNAX), Israel’s largest manufacturer of medical cannabis products, and its partner, Neuraxpharm, Europe’s leading pharmaceutical company specialized in the central nervous system (CNS) today announced that they are expanding ... Read More

France Supports Medical Cannabis During a United Nations Meeting

For the first time in nearly a century, France vigorously defended the therapeutic potential of cannabis at the United Nations this week. The European nation is calling the historic World Health Organization (WHO) recommendation to declassify medical cannabis from Schedule IV “necessary.”  Opposite of how the United States schedules narcotics, with ... Read More